1. Home
  2. FLOC vs EVO Comparison

FLOC vs EVO Comparison

Compare FLOC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowco Holdings Inc.

FLOC

Flowco Holdings Inc.

N/A

Current Price

$22.97

Market Cap

806.0M

Sector

Industrials

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.90

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLOC
EVO
Founded
1996
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
806.0M
778.3M
IPO Year
2024
2007

Fundamental Metrics

Financial Performance
Metric
FLOC
EVO
Price
$22.97
$1.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$28.50
$7.00
AVG Volume (30 Days)
505.5K
45.9K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$759,719,000.00
N/A
Revenue This Year
$22.92
$1.37
Revenue Next Year
$8.59
$10.05
P/E Ratio
$45.02
N/A
Revenue Growth
41.93
N/A
52 Week Low
$14.03
$1.90
52 Week High
$28.26
$4.27

Technical Indicators

Market Signals
Indicator
FLOC
EVO
Relative Strength Index (RSI) 59.55 35.64
Support Level $22.54 N/A
Resistance Level $24.37 $3.84
Average True Range (ATR) 0.99 0.05
MACD 0.34 0.02
Stochastic Oscillator 76.29 0.97

Price Performance

Historical Comparison
FLOC
EVO

About FLOC Flowco Holdings Inc.

Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: